Back

Xylazine Use Among People who Inject Drugs, Philadelphia 2022

This one-hour, on-demand, journal article-based activity compares characteristics of participants who reported using xylazine to those who reported not using xylazine in the past 12 months. Data from the National HIV Behavioral Surveillance Survey among persons who inject drugs (PWIDs) in Philadelphia was reviewed to better identify individuals at risk and inform patients and clinicians about xylazine risk factors.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

This is a journal-based activity. Credit is earned after completing the required reading and assessment; the amount shown is the provider-reported available credit.

IPCE CreditsUp to 1 creditAAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 creditSocial WorkUp to 1 credit

MOC types

ABS — Accredited CMEUp to 1 pointABA — Lifelong LearningUp to 1 pointABIM — Medical KnowledgeUp to 1 pointABS — Self-AssessmentUp to 1 pointABP — Lifelong Learning and Self-AssessmentUp to 1 pointABIM — Patient SafetyUp to 1 pointABA — Patient SafetyUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 7 specialties.

Pricing

Fee varies

This provider typically $39–149

See fees on elearning.asam.org

Listed by the provider

  • Journal-based
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Fee varies · this provider typically $39–149
  • Released
    Mar 14, 2024
  • Last day to claim credit
    Mar 15, 2027 5 months left